- Home
- IQST vs OKYO Comparison
IQST vs OKYO Comparison
Compare IQST & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQST
- OKYO
- Stock Information
- Founded
- IQST 2011
- OKYO 2007
- Country
- IQST United States
- OKYO United Kingdom
- Employees
- IQST N/A
- OKYO N/A
- Industry
- IQST
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IQST
- OKYO Health Care
- Exchange
- IQST NYSE
- OKYO Nasdaq
- Market Cap
- IQST 34.0M
- OKYO 37.0M
- IPO Year
- IQST N/A
- OKYO 2022
- Fundamental
- Price
- IQST $9.85
- OKYO $2.59
- Analyst Decision
- IQST
- OKYO Strong Buy
- Analyst Count
- IQST 0
- OKYO 1
- Target Price
- IQST N/A
- OKYO $7.00
- AVG Volume (30 Days)
- IQST 166.4K
- OKYO 213.4K
- Earning Date
- IQST 08-11-2025
- OKYO 08-12-2025
- Dividend Yield
- IQST N/A
- OKYO N/A
- EPS Growth
- IQST N/A
- OKYO N/A
- EPS
- IQST N/A
- OKYO N/A
- Revenue
- IQST $289,438,380.00
- OKYO N/A
- Revenue This Year
- IQST N/A
- OKYO N/A
- Revenue Next Year
- IQST N/A
- OKYO N/A
- P/E Ratio
- IQST N/A
- OKYO N/A
- Revenue Growth
- IQST 69.01
- OKYO N/A
- 52 Week Low
- IQST $7.47
- OKYO $0.81
- 52 Week High
- IQST $19.00
- OKYO $3.11
- Technical
- Relative Strength Index (RSI)
- IQST N/A
- OKYO 61.12
- Support Level
- IQST N/A
- OKYO $2.05
- Resistance Level
- IQST N/A
- OKYO $2.57
- Average True Range (ATR)
- IQST 0.00
- OKYO 0.31
- MACD
- IQST 0.00
- OKYO -0.00
- Stochastic Oscillator
- IQST 0.00
- OKYO 48.18
About IQST IQSTEL INC
iQSTEL Inc is a technology company offering a wide array of services to the telecom and Internet industry. The business divisions of the company are Telecommunication including VoIP, SMS, International Fiber-Optic, Proprietary Internet of Things (IoT), and a Proprietary Mobile Portability Blockchain Platform; the Fintech division includes remittances services, top-up services, Master Card Debit Card, a USA Bank Account, and a Mobile App; Electric Vehicles division offers Electric Motorcycles and plans to launch a Mid Speed Car; and the Metaverse division includes Metaverse platform to access products, services, content, entertainment, information, customer support, and more in a virtual 3D interface. Geographically, it derives a majority of its revenue from the USA.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.